卡皮库亚转录抑制因子(CIC)重排肉瘤携带CIC-LEUTX融合并累及肾脏:一例罕见病例报告。

IF 1.5 4区 医学 Q4 ONCOLOGY Translational cancer research Pub Date : 2024-10-31 Epub Date: 2024-10-24 DOI:10.21037/tcr-24-524
Jing Zhu, Chao Chen, Yan Li
{"title":"卡皮库亚转录抑制因子(CIC)重排肉瘤携带CIC-LEUTX融合并累及肾脏:一例罕见病例报告。","authors":"Jing Zhu, Chao Chen, Yan Li","doi":"10.21037/tcr-24-524","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Capicua transcriptional repressor (CIC)-rearranged sarcoma (CRS) is a rare and highly aggressive undifferentiated small round cell sarcoma (USRCS), which genetically displays a characteristic gene fusion between <i>CIC</i> gene with other genes such as <i>DUX4</i>.</p><p><strong>Case description: </strong>We report a rare case with <i>CIC-LEUTX</i> fusion. The 45-year-old male patient presented to our department with frequent dry cough and lumbar pain. Computed tomography (CT) scan indicated multiple pulmonary nodules on both sides, hilar lymph node enlargement, left lower lobe infection and presence of pleural effusion in left quadrant. Enlargement and uneven density were seen in the left kidney, together with perinephric exudate, renal calculi, thickening and filling deficiency in renal veins, and small retroperitoneal lymph nodes. Immunohistochemistry (IHC) showed negativity in CK7, CK20, CD10, vimentin, PAX-8, P63, MelanA and synapatophysin, but GATA3 and CK were positive. RNA-based next generation sequencing (NGS) detection revealed CRS of gene fusion in <i>CIC</i> (exon 20) and <i>LEUTX</i> (exon 3). After treatment with a variety of targeted and chemotherapy drugs, the patient showed a poor response with a survival time of merely 7 months.</p><p><strong>Conclusions: </strong>This case of USRCS harboring <i>CIC-LEUTX</i> fusion with renal involvement could help to expand our understanding on the diagnosis and treatment of CRS harboring <i>CIC-LEUTX</i> fusion.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"13 10","pages":"5711-5718"},"PeriodicalIF":1.5000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543050/pdf/","citationCount":"0","resultStr":"{\"title\":\"Capicua transcriptional repressor (CIC)-rearranged sarcoma harboring <i>CIC-LEUTX</i> fusion with renal involvement: a rare case report.\",\"authors\":\"Jing Zhu, Chao Chen, Yan Li\",\"doi\":\"10.21037/tcr-24-524\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Capicua transcriptional repressor (CIC)-rearranged sarcoma (CRS) is a rare and highly aggressive undifferentiated small round cell sarcoma (USRCS), which genetically displays a characteristic gene fusion between <i>CIC</i> gene with other genes such as <i>DUX4</i>.</p><p><strong>Case description: </strong>We report a rare case with <i>CIC-LEUTX</i> fusion. The 45-year-old male patient presented to our department with frequent dry cough and lumbar pain. Computed tomography (CT) scan indicated multiple pulmonary nodules on both sides, hilar lymph node enlargement, left lower lobe infection and presence of pleural effusion in left quadrant. Enlargement and uneven density were seen in the left kidney, together with perinephric exudate, renal calculi, thickening and filling deficiency in renal veins, and small retroperitoneal lymph nodes. Immunohistochemistry (IHC) showed negativity in CK7, CK20, CD10, vimentin, PAX-8, P63, MelanA and synapatophysin, but GATA3 and CK were positive. RNA-based next generation sequencing (NGS) detection revealed CRS of gene fusion in <i>CIC</i> (exon 20) and <i>LEUTX</i> (exon 3). After treatment with a variety of targeted and chemotherapy drugs, the patient showed a poor response with a survival time of merely 7 months.</p><p><strong>Conclusions: </strong>This case of USRCS harboring <i>CIC-LEUTX</i> fusion with renal involvement could help to expand our understanding on the diagnosis and treatment of CRS harboring <i>CIC-LEUTX</i> fusion.</p>\",\"PeriodicalId\":23216,\"journal\":{\"name\":\"Translational cancer research\",\"volume\":\"13 10\",\"pages\":\"5711-5718\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543050/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/tcr-24-524\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-524","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:卡皮夸转录抑制因子(CIC)重组肉瘤(CRS)是一种罕见的高侵袭性未分化小圆形细胞肉瘤(USRCS),在遗传学上表现出CIC基因与DUX4等其他基因融合的特征:我们报告了一例罕见的 CIC-LEUTX 融合病例。这名 45 岁的男性患者因频繁干咳和腰痛来我科就诊。计算机断层扫描(CT)显示患者两侧肺部多发结节,肺门淋巴结肿大,左下叶感染,左象限胸腔积液。左肾肿大,密度不均,肾周渗出物,肾结石,肾静脉增粗,充盈不足,腹膜后淋巴结肿大。免疫组化(IHC)显示,CK7、CK20、CD10、波形蛋白、PAX-8、P63、MelanA和突触素阴性,但GATA3和CK阳性。基于 RNA 的新一代测序(NGS)检测显示,CIC(20 号外显子)和 LEUTX(3 号外显子)的基因融合为 CRS。经过多种靶向药物和化疗药物治疗后,患者的反应不佳,存活时间仅为 7 个月:本例携带CIC-LEUTX基因融合并累及肾脏的USRCS病例有助于拓展我们对携带CIC-LEUTX基因融合的CRS诊断和治疗的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Capicua transcriptional repressor (CIC)-rearranged sarcoma harboring CIC-LEUTX fusion with renal involvement: a rare case report.

Background: Capicua transcriptional repressor (CIC)-rearranged sarcoma (CRS) is a rare and highly aggressive undifferentiated small round cell sarcoma (USRCS), which genetically displays a characteristic gene fusion between CIC gene with other genes such as DUX4.

Case description: We report a rare case with CIC-LEUTX fusion. The 45-year-old male patient presented to our department with frequent dry cough and lumbar pain. Computed tomography (CT) scan indicated multiple pulmonary nodules on both sides, hilar lymph node enlargement, left lower lobe infection and presence of pleural effusion in left quadrant. Enlargement and uneven density were seen in the left kidney, together with perinephric exudate, renal calculi, thickening and filling deficiency in renal veins, and small retroperitoneal lymph nodes. Immunohistochemistry (IHC) showed negativity in CK7, CK20, CD10, vimentin, PAX-8, P63, MelanA and synapatophysin, but GATA3 and CK were positive. RNA-based next generation sequencing (NGS) detection revealed CRS of gene fusion in CIC (exon 20) and LEUTX (exon 3). After treatment with a variety of targeted and chemotherapy drugs, the patient showed a poor response with a survival time of merely 7 months.

Conclusions: This case of USRCS harboring CIC-LEUTX fusion with renal involvement could help to expand our understanding on the diagnosis and treatment of CRS harboring CIC-LEUTX fusion.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
期刊最新文献
Construction and validation of prognostic model for colorectal mucinous adenocarcinoma patients and identification of a new prognosis related gene FAM174B. Erratum: Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma. Establishment and validation of a prediction model for gastric cancer with perineural invasion based on preoperative inflammatory markers. Establishment and verification of a prognostic immune cell signature-based model for breast cancer overall survival. Exosomal AHSG in ovarian cancer ascites inhibits malignant progression of ovarian cancer by p53/FAK/Src signaling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1